CS Paper Radar

Contrast Enhancement or Noise Reduction? On Improving Cervical Cancer Classification

Ach Khozaimi, Ulfatun Nahdhiyah

cs.CV ·submitted 2026-10-08 01:57 UTC · v1
published

Abstract

Purpose: Cervical cancer is one of the leading causes of mortality worldwide. Deep learning has shown promising performance in medical image classification. The influence of image preprocessing algorithms on classification performance remains insufficiently investigated in the literature. This research aims to evaluate the impact of image preprocessing algorithms on the performance of CNNs for Pap smear image classification. Methods: Three CNN architectures (ResNet-34, MobileNet-V2, and DenseNet-121) were trained and evaluated using the SIPaKMeD dataset. Two preprocessing algorithms were applied: the PMD filter for noise reduction and CLAHE for contrast enhancement. The model performance was assessed using a confusion matrix. Results: Preprocessing improved the classification performance of all models. CLAHE significantly increased the accuracy of ResNet-34 from 76.73% to 84.16% and DenseNet-121 from 76.73% to 84.16%. The PMD filter yielded limited improvement and slightly reduced the MobileNet-V2 performance. Novelty: This research provides a systematic comparison of contrast enhancement and noise reduction techniques across CNN architectures. This research demonstrates that contrast enhancement is more effective than noise reduction in improving CNN performance. The research provides new pipelines for improving cervical cancer classification.

DOI
10.15294/sji.v13i3.48099

Closest papers

Nearest neighbours by meaning across the whole index.

Deep Learning for Cervical Cytology Screening: Methods, Algorithms, Challenges and Prospects

cs.CV ·2026-11-01 ·Jiang Yangbo, Zheng Nenggan
benchmark similarity 0.64
Abstract

Cervical cancer remains a leading cause of cancer death among women, with more than 90\% of deaths occurring in low- and middle-income countries, where cytology screening is constrained by a shortage of trained cytopathologists. Deep learning has made automated cytology screening increasingly feasible, but the literature is fragmented across cell, patch and whole-slide-image scales, task formulations and supervision regimes, hindering comparison and clinical translation. This Review synthesizes the deep learning literature for cervical cytology screening, organizing the field along three axes---data scale, functional task and supervision---and distinguishing two clinical roadmaps: whole-slide-image confidence aggregation and cell-level detection with Bethesda classification. We examine 16 publicly available or publicly documented cytology datasets alongside the CAISHI histopathology dataset, compare quantitative performance while exposing incomparable metrics and data leakage, and assess commercial systems, regulatory status, HPV-era screening pathways and low-resource deployment. Single-cell accuracy on Herlev and SIPaKMeD has plateaued, but this reflects benchmark saturation rather than clinical readiness; prospective and randomized evidence is emerging but remains limited. We consolidate the evidence into five challenge areas---data and benchmarks, architecture and label-efficient learning, trustworthy AI, clinical translation and health economics, and evaluation and reproducibility---and provide an evidence-to-agenda map and a deployment decision matrix. Progress now depends on multi-center benchmarks, externally validated label-efficient methods, calibrated and fair predictions, and pragmatic clinical trials rather than further gains on saturated single-cell benchmarks.

0.09

Comprehensive Benchmarking of Deep Learning Architectures for Lung Cancer Histopathology

cs.CV cs.AI ·2026-08-16 ·Hadi Hasan, Safaa Salman, Lama Sleem, Ralph Mouawad, Ali Chehab
benchmark similarity 0.64
Abstract · 8 pages

Lung cancer remains the leading cause of cancer-related mortality worldwide, while histopathological diagnosis is often affected by inter-observer variability and the substantial workload associated with manual slide examination. Although deep learning has shown considerable potential in computational pathology, comprehensive benchmarks that integrate tissue classification and region segmentation within a unified analytical framework remain limited. This study presents a two-stage deep learning framework for multi-class tissue classification and pixel-level histopathological region segmentation, accompanied by a systematic comparison of state-of-the-art architectures at each stage. For tissue classification, six models, a custom convolutional neural network, VGG16, DenseNet, MobileNetV3, a custom Vision Transformer, and YOLO11, are evaluated on a combined dataset of 39,000 images derived from LC25000 and LungHist700. The models distinguish between adenocarcinoma, squamous cell carcinoma, and normal lung tissue. YOLO11 achieves the best classification performance, with an accuracy of 98.38%, a five-fold cross-validation accuracy of 98.21 +/- 0.35%, and a macro F1-score of 0.98. For region segmentation, U-Net, ResNet-encoder U-Net, DeepLabV3+, and YOLO11-seg are evaluated using the GlaS gland segmentation benchmark. DeepLabV3+ obtains the highest Intersection over Union of 0.80 and a Dice score of 0.89, while YOLO11-seg achieves a comparable Intersection over Union of 0.79 using approximately 14x fewer parameters. The best-performing classification and segmentation models are subsequently integrated into an end-to-end framework, providing an accurate, computationally efficient, and reproducible baseline for automated histopathological image analysis.

0.40

Robust Lightweight Deep Learning Models for Oral Cancer Screening

cs.AI ·2026-08-21 ·Siddhant Bharadwaj, Aakash Shedsale, Tejashree Subramanya, Mohd. Azfar, Praveen Birur +4 more
published similarity 0.64
Abstract · 10 pages, 3 figures, Paper accepted for the 6th International Conference on AI-ML Systems, 2026

Oral cancer is a leading cause of mortality in low-to-middle-income countries, where a shortage of specialists delays diagnosis. While point-of-care screening via smartphones offers a scalable solution, developing robust AI for resource-constrained settings poses significant challenges, including class imbalance in training data, variable data quality, and computational constraints on edge devices. In this paper, we present the optimisation of lightweight deep learning models for smartphone-based oral cancer screening. Using a diverse, multi-centre retrospective dataset of approximately 30,000 images acquired over a decade, we systematically evaluate state-of-the-art convolutional, transformer, and hybrid architectures. Through rigorous pipeline ablation, we demonstrate that directly optimising hybrid architectures for the edge strictly outperforms computationally heavy paradigms, such as large models or knowledge distillation. Furthermore, interpretability analysis and simulated noise-stress tests revealed that the system anchors on clinical features and remains robust to unstructured sensor noise, despite vulnerabilities to impulse bit errors. In the held-out test set, our optimised MobileViTv2 models achieved an average sensitivity of 83.2 $\pm$ 1.5% and an average specificity of 86.0 $\pm$ 0.8%, with the best model exhibiting 87.4% sensitivity, 86.5% specificity, and a critical negative predictive value of 97.2% with reference to specialist labels. These results confirm that with targeted architectural selection and streamlined optimisation, interpretable and robust lightweight AI models exhibit high potential for edge deployment to enable automated triage in primary care settings.

0.30

A Comparative Study of GAN-Based Deep Learning Models for Pneumonia Detection in Chest X-Rays

cs.CV ·2026-09-05 ·Roshan Paudel, Aashish Ghimire, Pramod Acharya
similarity 0.63
Abstract

This study evaluates pneumonia classification in chest X-rays using VGG19, MobileNetV2, ResNet50, and a custom CNN, and explores Generative Adversarial Network (GAN)-based synthetic data augmentation. MobileNetV2 achieved the highest reported accuracy of 88% with balanced class-wise performance. The custom CNN achieved pneumonia recall of 92.67% and precision of 79.43%, highlighting a precision-recall trade-off. Accuracy, F1-score, precision, recall, confusion matrices, and training curves were used to assess performance. Synthetic pneumonia images were combined with real images to investigate whether augmentation could improve classification performance. In the reported VGG19 comparison, augmented-data training accuracy reached approximately 100%, while validation accuracy remained near 50%, below the real-data validation accuracy. This experiment therefore did not demonstrate a validation-performance benefit from GAN augmentation. The classifier comparison highlights differences in accuracy and pneumonia recall, while the augmentation experiment indicates the need for further evaluation of synthetic-image quality and training settings.

0.26

Artificial Intelligence Algorithms for the Detection of Pathologies Related to Lung Cancer through Image Analysis using Convolutional Neural Networks and Data Augmentation: a systematic mapping of the literature

cs.LG cs.CL ·2026-09-09 ·Pablo Ramirez Amador
similarity 0.63
Abstract

Lung cancer is one of the leading causes of death worldwide, and its early diagnosis is crucial to improving patients prognosis and quality of life. However, the process of interpreting medical images for the detection of lung cancer is complex and requires trained experts. In this context, artificial intelligence (AI) and deep learning (DL) emerge as potential tools to automate and optimize image analysis. The objective of this work is to review the most recent and relevant applications of AI and DL in the field of radiology for the detection of lung cancer. To this end, an exhaustive search was carried out in scientific databases such as PubMed,IEEEXPLORE, Scopus and Web of Science, and 96 articles published from 2015 to the present addressing the use of AI and DL in biomedical engineering were selected. Emphasis is placed on the use of convolutional neural networks (CNN) with transfer learning and Data Augmentation as promising techniques to improve the accuracy and efficiency of the image interpretation process. The results show that the use of AI and DL can offer an effective alternative for the early diagnosis of lung cancer, with high sensitivity and specificity. However, current limitations and challenges that must be addressed to guarantee its responsible and safe application in clinical practice are also identified, such as the lack of standardized data, the ex plainability of the models, patient privacy, and the ethical and social implications. It is concluded that the use of AI and DL can have a positive impact on the care of patients with lung cancer, but further research and regulation are required to ensure its quality and reliability.

0.15

Image-Based Breast Implant Detection for Mammography Dataset Curation and Near-Real-Time Deployment: Comparing Foundation Models and Task-Specific Convolutional Models

eess.IV cs.CVq-bio.TO ·2026-10-01 ·Vasisht Ishwar, Hari Trivedi, Young Seok Jeon, Beatrice Brown-Mulry, Frank Li +3 more
similarity 0.63
Abstract · 15 pages, 6 figures, 2 tables. Submitted to the Journal of Imaging Informatics in Medicine

Purpose: To evaluate the performance-feasibility tradeoffs of foundation models (FMs) and task-specific convolutional neural networks (CNNs) trained from scratch for breast implant classification in 2D mammography, with emphasis on suitability for near real-time clinical deployment. Methods: We evaluated four models: two FMs (RAD-DINO and MammoCLIP) and two CNNs trained from scratch for implant prediction (ResNet18 and our lightweight ResNetLite). Using the Emory Breast Imaging Dataset, 5,000 unilateral screening mammograms were used for training/validation and 1,000 manually reviewed unilateral images were held out for testing. For the FMs, global image embeddings from the pretrained encoder were classified using a support vector machine (SVM). The CNNs were trained end-to-end on 2D mammograms, with ResNetLite optimized via grid search over depth and width to balance accuracy and efficiency. Performance was evaluated using AUROC, sensitivity, specificity, accuracy, embedding visualization, and inference-latency. Results: All models demonstrated strong performance on held-out test data (n = 1,000). MammoCLIP achieved the highest AUROC (0.999) with the quickest training time of 493 seconds. RAD-DINO achieved the highest sensitivity (0.980; accuracy 0.989) but had the slowest inference and training times. ResNet18 and MammoCLIP achieved comparable accuracy (0.985). ResNetLite showed no statistically significant difference from ResNet18 (AUROC 0.993; accuracy 0.976) despite using only 1.4% of ResNet18's parameters, and had the fastest inference time. Conclusion: FMs and task-specific CNN models reliably detect breast implants on 2D mammography. Model selection is best guided by deployment context: MammoCLIP for GPU-equipped hospital settings requiring scalable integration, and lightweight CNNs such as ResNetLite for resource-constrained or edge deployments.

0.12

Benchmarking CNNs, Vision Transformers, and Foundation Models for Explainable Brain Tumor MRI Classification: Calibration, Decision Analysis, and External Validation

cs.CV ·2026-11-09 ·Akwasi Asare
similarity 0.62
Abstract · Under review at Scientific Report Journal, Springer

Deep learning models for brain tumor MRI classification are usually compared by accuracy alone, on public datasets whose independence is rarely checked. We benchmarked six architectures: two convolutional networks (EfficientNetV2-M and ConvNeXt-V2-Tiny), two vision transformers (Swin-V2-S and ViT-L/16), and two foundation models (DINOv2-L and MedSigLIP-448), for four-class classification of 7,216 public MRI images. We assessed accuracy, calibration, explainability, ensembles, and decision curves, with every fitted quantity estimated on validation data only. Pixel-verified duplicate screening showed that 36% of the test images had a near-duplicate in the training data. Test accuracy ranged from 94.5% to 95.6%, with no pairwise difference after Holm correction, and fell to 90.3% to 91.7% on the 773 test images free of duplicates and shared patients. Ensembles did not outperform the best single model. Attribution maps passed a model-randomization test but localized expert-annotated tumors poorly. On 1,675 external BDNeuro-MRI images that did not duplicate the training data, accuracy ranged from 77.6% (MedSigLIP-448) to 95.0% (ViT-L/16), and 12 of 15 pairwise differences were significant. Internal accuracy on this public collection therefore did not distinguish the architectures, whereas the duplicate-filtered external test did.

0.16

Deep-Learning Algorithm for Indeterminate Thyroid Nodules: Comparison and Combination with Molecular Testing

cs.CV q-bio.QMeess.IV ·2026-10-16 ·Jichen Yang, Jeffrey Ashton, Jikai Zhang, Maciej A. Mazurowski, Benjamin Wildman-Tobriner
similarity 0.62
Abstract · 16 pages, 7 figures, 8 tables (3 supplementary)

Thyroid nodules with indeterminate cytology (Bethesda III) carry an intermediate risk of malignancy, and molecular testing is widely used to decide between surgery and surveillance, but it is costly and not universally available. We investigated whether a convolutional neural network (CNN) applied to routine ultrasound images can stratify Bethesda III nodules, and how it compares and combines with molecular testing. We retrospectively identified 466 nodule records from 418 patients who underwent molecular testing (Afirma or ThyroSeq). A CNN pre-trained on determinate nodules was adapted to indeterminate nodules with soft labels and transfer learning. After removal of duplicate records, 119 nodules with surgical pathology were used for development and 47 were held out for testing. On the test set, the deep learning (DL) model achieved an AUC of 0.73 (95% CI 0.51-0.94), compared with 0.55 (0.38-0.71) for molecular testing (P = 0.15). At a cut-off inherited from the original algorithm, the DL model was more specific than molecular testing (0.95 vs 0.32; P < 0.001), with a higher positive predictive value (0.67 vs 0.21), a lower sensitivity (0.44 vs 0.78; P = 0.25) and a similar negative predictive value (0.88 vs 0.86). All six DL-positive test nodules were molecular-positive, and the DL output split the molecular-positive nodules into a high-risk (4/6 malignant) and a lower-risk group (3/27 malignant; P = 0.01). Surgical verification was strongly driven by the molecular result (99% of positive vs 19% of negative results), and molecular-test accuracy depended on the platform. A logistic regression of the DL output, nodule size and the molecular result dropped the DL term and did not improve on the DL output alone. Ultrasound DL complemented molecular testing for Bethesda III nodules, in particular by identifying molecular-positive nodules at lower risk of malignancy.

0.14